Freenome, Inc

FRNM Healthcare Diagnostics & Research

EPS
−115.2%
Free cash flow
+12.1%

Quarter to June 2026, against a year earlier

10.15 0.32 −3.06%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+6 more TTM periods

(95.60%) (24.23%) (2.67%) 17.81%
ROA
2.67% 0.92% 0.12% (0.86%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
736.50% (62.19%) (4.86%) 26.43%
Free Cash Flow per Share
(0.26) (0.35) (0.38) (0.37)
Free Cash Flow
(0.63) (0.86) (0.92) (0.91)
Other line items

Show all line items

Columns are period end dates